Literature DB >> 17035427

Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease.

Aryeh Fischer1, Richard T Meehan, Carol A Feghali-Bostwick, Sterling G West, Kevin K Brown.   

Abstract

STUDY
OBJECTIVES: To describe the characteristics of systemic sclerosis sine scleroderma (ssSSc)-associated interstitial lung disease (ILD) presenting as idiopathic interstitial pneumonia (IIP).
DESIGN: Retrospective review of six patients with ssSSc-associated ILD diagnosed after referral for evaluation of IIP. MEASUREMENT AND
RESULTS: All patients were white, their mean age was 56 years (range, 37 to 86), and gender was evenly divided. Sclerodactyly, skin thickening, and digital edema were absent in all patients. All patients had scattered telangiectasia, and four patients had Raynaud phenomenon with abnormal nailfold capillaroscopy findings. All described gastroesophageal reflux, and three patients had esophageal dysmotility by esophagography. All had restrictive pulmonary physiology and a reduced diffusion capacity. High-resolution CT revealed nonspecific interstitial pneumonia (NSIP) or usual interstitial pneumonia (UIP) radiographic patterns. Of the three patients who underwent surgical lung biopsy, two patients had NSIP and one patient had UIP pathologic patterns. Five patients had asymptomatic pericardial effusions and elevated pulmonary artery pressures by echocardiography. All patients had nucleolar-staining anti-nuclear antibodies (ANAs), and one patient was anti-Scl-70 positive. All five anti-Scl-70-negative patients were anti-Th/To positive, and the anti-Scl-70-positive patient was anti-Th/To negative.
CONCLUSIONS: In the presentation of an IIP, the presence of a nucleolar-staining ANA, telangiectasia, Raynaud phenomenon with abnormal capillaroscopy findings, gastroesophageal reflux, or pericardial disease suggests underlying systemic sclerosis. These findings should aid clinicians in the evaluation and treatment of patients with otherwise undefined ILD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035427     DOI: 10.1378/chest.130.4.976

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  19 in total

1.  When to stop in the quest of formes frustes of connective tissue disease?

Authors:  Vincent Cottin; Jean-Christophe Lega; Nicole Fabien; Jean-François Cordier
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 2.980

2.  Connective tissue disease-associated interstitial lung disease: a call for clarification.

Authors:  Aryeh Fischer; Sterling G West; Jeffrey J Swigris; Kevin K Brown; Roland M du Bois
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

3.  Interstitial Lung Disease Associated with Connective Tissue Diseases.

Authors:  Ruben A Peredo; Vivek Mehta; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease.

Authors:  Kristen L Veraldi; Eileen Hsu; Carol A Feghali-Bostwick
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

Review 5.  Coagulation and autoimmunity in scleroderma interstitial lung disease.

Authors:  Anna Ludwicka-Bradley; Richard M Silver; Galina S Bogatkevich
Journal:  Semin Arthritis Rheum       Date:  2010-12-17       Impact factor: 5.532

6.  Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.

Authors:  Angela Ceribelli; Malgorzata E Krzyszczak; Yi Li; Steven J Ross; Jason Y F Chan; Edward K L Chan; Rufus W Burlingame; Tyler T Webb; Michael R Bubb; Eric S Sobel; Westley H Reeves; Minoru Satoh
Journal:  Arthritis Res Ther       Date:  2011-07-22       Impact factor: 5.156

Review 7.  Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others.

Authors:  Minoru Satoh; Angela Ceribelli; Tomoko Hasegawa; Shin Tanaka
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-08       Impact factor: 10.817

Review 8.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

9.  Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia.

Authors:  Aryeh Fischer; Jeffrey J Swigris; Roland M du Bois; David A Lynch; Gregory P Downey; Gregory P Cosgrove; Stephen K Frankel; Evans R Fernandez-Perez; JoAnn Z Gillis; Kevin K Brown
Journal:  Respir Med       Date:  2009-06-03       Impact factor: 3.415

Review 10.  The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications.

Authors:  Sophie P Toya; George E Tzelepis
Journal:  Rheumatol Int       Date:  2009-02-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.